Skip to main content

Table 4 Cause of death among patients with Waldenström macroglobulinemia in Korea

From: Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study

Condition (ICD-10 code)

Male

Female

2003–2009

2010–2016

Totala (%)

Neoplasm

 Malignant neoplasm (C00-C97 except for C88)

63

19

33

49

82 (39.05)

 Waldenström macroglobulinemia (C88)

83

19

54

48

102 (48.57)

 Other neoplasm (D00-D48)

1

0

0

1

1 (0.48)

Hematology (D50-D89)

2

1

1

2

3 (1.43)

Circulatory system

 Cardiovascular (I00-I52)

2

2

1

3

4 (1.90)

 Cerebrovascular (I60-I69)

1

1

0

2

2 (0.95)

Infection (A00-B99)

0

2

1

1

2 (0.95)

Respiratory system (J00-J99)

4

1

2

3

5 (2.38)

Digestive system (K00-K93)

1

0

0

1

1 (0.48)

Musculoskeletal system and connective tissue (M00-M99)

1

0

1

0

1 (0.48)

Trauma (S00-S99, T00-T98, V01-V99, W00-W99, X00-X99, and Y00-Y98)

2

0

1

1

2 (0.95)

Other (R00-R99, and Z00-Z99)

5

0

2

3

5 (2.38)

Total

165

45

96

114

210 (100.00)

  1. aA total of 7 out of 217 patients who died from Waldenström macroglobulinemia had unknown or unspecified causes